preproenkephalin and Trigeminal-Neuralgia

preproenkephalin has been researched along with Trigeminal-Neuralgia* in 1 studies

Other Studies

1 other study(ies) available for preproenkephalin and Trigeminal-Neuralgia

ArticleYear
Efficacy of Herpes Simplex Virus Vector Encoding the Human Preproenkephalin Gene for Treatment of Facial Pain in Mice.
    Journal of oral & facial pain and headache, 2016,Winter, Volume: 30, Issue:1

    To determine whether herpes simplex virus-based vectors can efficiently transduce mouse trigeminal ganglion (TG) neurons and attenuate preexisting nerve injury-induced whisker pad mechanical hypersensitivity in a trigeminal inflammatory compression (TIC) neuropathic pain model.. Tissue transduction efficiencies of replication-conditional and replication-defective vectors to mouse whisker pads after topical administration and subcutaneous injection were assessed using quantitative real-time PCR (qPCR). Tissue tropism and transgene expression were assessed using qPCR and reverse-transcriptase qPCR following topical application of the vectors. Whisker pad mechanical sensitivities of TIC-injured mice were determined using graduated von Frey fibers before and after application of human preproenkephalin expressing replication-conditional vector (KHPE). Data were analyzed using one-way analysis of variance (ANOVA) and post hoc tests.. Transduction of target TGs was 8- to 50-fold greater after topical application than subcutaneous injection and ≥ 100-fold greater for replication-conditional than replication-defective vectors. Mean KHPE loads remained constant in TGs (4.5-9.8 × 10(4) copies/TG) over 3 weeks but were below quantifiable levels (10 copies/tissue) within 2 weeks of application in other nontarget cephalic tissues examined. Transgene expression in TGs was maximal during 2 weeks after topical application (100-200 cDNA copies/mL) and was below quantifiable levels (1 cDNA copy/mL) in all nontarget tissues. Topical KHPE administration reduced TIC-related mechanical hypersensitivity on whisker pads 4-fold (P < .05) for at least 1 week.. Topically administered KHPE produced a significant antinociceptive effect in the TIC mouse model of chronic facial neuropathic pain. This is the first report in which a gene therapeutic approach reduced trigeminal pain-related behaviors in an established pain state in mice.

    Topics: Administration, Topical; Animals; Chronic Pain; Disease Models, Animal; Enkephalins; Facial Pain; Genetic Therapy; Genetic Vectors; Humans; Injections, Subcutaneous; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Protein Precursors; Simplexvirus; Touch; Transduction, Genetic; Transfection; Transgenes; Trigeminal Ganglion; Trigeminal Neuralgia

2016